Reyedar

Reyedar is a Dutch deeptech medical technology company focused on early, non-invasive screening for age-related degenerative diseases, including glaucoma, Parkinson’s disease, and multiple sclerosis. Originally known as Reperio Medtech, Reyedar is a spin-off from the Ophthalmology Department of the University Medical Center Groningen. The company utilizes eye-tracking technology combined with deep learning algorithms to analyze eye movements, offering insights into brain and neurological health. Their core product is an AI-powered infrared eye-tracking system integrated into user-friendly glasses. This system automatically measures eye movements and processes the data through proprietary algorithms to detect changes that may indicate neurodegenerative or visual disorders. Reyedar's screening test, SONDA, provides a fast and objective alternative to traditional diagnostic methods, enhancing patient experience and clinical workflow in hospitals and private clinics. The company also supports clinical research centers with a plug-and-play solution for eye movement data collection, addressing common challenges in the field. Reyedar has secured €3 million in funding to support its growth and product launch in the eye care market.

• Employees 9
• Founded 2020
• Annual Revenue $1000000
• Total Funding $3268950